CATALOGO DEI PRODOTTI DELLA RICERCA

DE NITTO, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.134
EU - Europa 1.655
AS - Asia 1.402
SA - Sud America 187
AF - Africa 64
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.448
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.090
RU - Federazione Russa 868
SG - Singapore 634
CN - Cina 259
IT - Italia 190
HK - Hong Kong 159
BR - Brasile 157
VN - Vietnam 144
DE - Germania 99
FR - Francia 99
IE - Irlanda 87
GB - Regno Unito 83
SE - Svezia 70
KR - Corea 66
FI - Finlandia 49
ES - Italia 34
IN - India 26
CA - Canada 23
JP - Giappone 21
TG - Togo 19
PL - Polonia 18
ID - Indonesia 16
BD - Bangladesh 15
BJ - Benin 14
MX - Messico 13
LT - Lituania 9
NG - Nigeria 9
NL - Olanda 9
AR - Argentina 8
IQ - Iraq 8
PH - Filippine 8
AT - Austria 7
BE - Belgio 7
UA - Ucraina 7
VE - Venezuela 7
TR - Turchia 6
UZ - Uzbekistan 6
ZA - Sudafrica 6
CO - Colombia 5
EC - Ecuador 5
IR - Iran 5
MA - Marocco 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
AZ - Azerbaigian 3
CH - Svizzera 3
JO - Giordania 3
KE - Kenya 3
PY - Paraguay 3
SA - Arabia Saudita 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
KG - Kirghizistan 2
LB - Libano 2
OM - Oman 2
RS - Serbia 2
TN - Tunisia 2
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
IS - Islanda 1
JM - Giamaica 1
LK - Sri Lanka 1
LV - Lettonia 1
MG - Madagascar 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
TH - Thailandia 1
Totale 5.448
Salva come PNG Salva come JPEG
Città #
Singapore 375
Ashburn 343
Dallas 311
San Jose 288
Moscow 264
Chandler 260
Hong Kong 157
The Dalles 111
Verona 86
Dublin 84
Beijing 59
Ho Chi Minh City 57
Munich 47
Los Angeles 39
Redmond 37
Columbus 33
Hanoi 30
New York 29
Lawrence 25
Princeton 25
London 24
Helsinki 23
Madrid 23
Buffalo 22
Seattle 21
Sindelfingen 20
Lomé 19
Tokyo 19
Wilmington 19
Redondo Beach 18
Seoul 18
Turku 16
São Paulo 15
Cotonou 14
Orem 14
Santa Clara 14
Jakarta 12
Poplar 12
Brooklyn 11
Council Bluffs 11
Montreal 11
Southend 11
Warsaw 11
Frankfurt am Main 10
Lappeenranta 10
Milan 10
Abuja 9
Jacksonville 9
Atlanta 8
Rome 8
Ancona 7
Ann Arbor 7
Boston 7
Brussels 7
Houston 7
Hải Dương 7
Amsterdam 6
Brasília 6
Chennai 6
Chicago 6
Denver 6
Guangzhou 6
Phoenix 6
Tashkent 6
Vienna 6
Bonndorf 5
Da Nang 5
Haiphong 5
Mexico City 5
Baghdad 4
Bexley 4
Biên Hòa 4
Calgary 4
Charlotte 4
Dhaka 4
Fairfield 4
Hangzhou 4
Johannesburg 4
Padova 4
Peschiera del Garda 4
Querétaro 4
San Francisco 4
Shanghai 4
Stockholm 4
Tianjin 4
Washington 4
Woodbridge 4
Amman 3
Ankara 3
Baku 3
Campinas 3
Can Tho 3
Caracas 3
Caxias do Sul 3
Curitiba 3
Dongguan 3
Levallois-perret 3
Manchester 3
Nairobi 3
Nanjing 3
Totale 3.329
Salva come PNG Salva come JPEG
Nome #
Bile Acids Quantification by Liquid Chromatography-Tandem Mass Spectrometry: Method Validation, Reference Range, and Interference Study 197
Clinical assessment of FREND COVID-19 Ag test in an unselected population referred for routine SARS-CoV-2 testing 184
Anti-spike S1 IgA, anti-spike trimeric IgG, and anti-spike RBD IgG response after BNT162b2 COVID-19 mRNA vaccination in healthcare workers 176
Anti-SARS-CoV-2 Receptor-Binding Domain Total Antibodies Response in Seropositive and Seronegative Healthcare Workers Undergoing COVID-19 mRNA BNT162b2 Vaccination 163
Comparison of five commercial anti-SARS-CoV-2 total antibodies and IgG immunoassays after vaccination with BNT162b2 mRNA 162
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series 154
Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers 153
Analytical evaluation of the novel Mindray high sensitivity cardiac troponin I immunoassay on CL-1200i 152
Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay 147
Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals 145
Preliminary evaluation of Roche Cobas Elecsys Anti-SARS-CoV-2 chemiluminescence immunoassay 144
Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity 143
Thrombin Generation in Patients with Coronavirus Disease 2019 142
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters 140
Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay 138
Real-world assessment of Fluorecare SARS-CoV-2 Spike Protein Test Kit 135
Clinical performance of the Roche Elecsys SARS-CoV-2 antigen fully automated electrochemiluminescence immunoassay 133
Performance of Fujirebio Espline SARS-CoV-2 rapid antigen test for identifying potentially infectious individuals 131
Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination 126
Association between viral load and positivization time of a SARS-CoV-2 rapid antigen test in routine nasopharyngeal specimens 122
Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay 121
Are anti-SARS-CoV-2 S/N IgG/IgM antibodies always predictive of previous SARS-CoV-2 infection? 114
Correlation Between Time to Positive Result of SARS-CoV-2 Rapid Antigen Self-Test and Viral Antigen Concentration 112
Clinical performance of Fujirebio Lumipulse G SARSCoV- 2 Ag chemiluminescent immunoassay 112
Longitudinal monitoring of anti-SARS-CoV-2 RBD IgG antibodies after BNT162b2 vaccination in healthcare workers 110
Humoral response post-BNT162b2 single booster in pre-vaccination baseline SARS-CoV-2 seronegative and seropositive subjects 108
Monoclonal gammopathy in SARS-CoV-2 infection 106
Cellular immunity against SARS-CoV-2 depends on the serological status 106
Accuracy of screening for hemolysis in plasma samples using a commercial urine dipstick 105
Impact of the COVID-19 pandemic on the volume of laboratory testing 104
Positivization time of a COVID-19 rapid antigen self-test predicts SARS-CoV-2 viral load: a proof of concept 101
Cost-effectiveness analysis of different COVID-19 screening strategies based on rapid or laboratory-based SARS-CoV-2 antigen testing 98
Serum C reactive protein predicts humoral response after BNT162b2 booster administration 96
Can cellular and humoral immunity predict response to BNT162b2 bivalent booster? 95
Three-month ad interim analysis of total anti-SARS-CoV-2 antibodies in healthy recipient of a single BNT162b2 vaccine booster 95
Impact of water temperature on reconstitution of quality controls for routine hemostasis testing 91
Machine learning model comparison in the screening of cholangiocarcinoma using plasma bile acids profiles 86
SARS-CoV-2 Omicron infection is associated with high nasopharyngeal viral load 85
Real-world assessment of the clinical performance of COVID-VIRO ALL IN rapid SARS-CoV-2 antigen test 84
Early kinetics of cellular immunity in recipients of bivalent BNT162b2 vaccine: a proof-of-concept study 79
Reliability of a single-nostril nasopharyngeal swab for diagnosing SARS-CoV-2 infection 77
Serum levels of prostate specific antigen (PSA) after primary vaccination with BNT162b2 74
Monitoring humoral and cellular immunity over 6 months after mRNA-based bivalent COVID-19 vaccine administration 69
Vaccination time does not influence total anti-SARS-CoV-2 antibodies response 68
Impact of BNT162b2 primary vaccination and homologous booster on anti-SARS-CoV-2 IgA antibodies in baseline seronegative healthcare workers 66
Variation of Total Anti-SARS-CoV-2 Antibodies After Primary BNT162b2 Vaccination and Homologous Booster 65
Evaluation of the acceptability of proposed hemolysis limits for Werfen ACL-TOP 750 CTS 65
Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers 62
Impact of hemolysis on coagulation testing: comparative analysis of two different analyzers using photometric and mechanical clot detection techniques 10
Totale 5.551
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.295
article - articoli 20.957
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 338
Totale 42.590
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 3 5 27
2021/2022228 31 44 7 9 12 7 5 7 17 7 27 55
2022/2023659 37 55 58 120 37 138 23 59 67 9 30 26
2023/2024408 20 30 19 46 61 50 44 64 3 22 39 10
2024/20251.091 59 72 41 165 54 55 34 58 135 98 131 189
2025/20263.080 220 189 275 504 811 212 331 181 223 134 0 0
Totale 5.551